Diutan Gum Approved by US EPA for Agricultural Chemical Applications
ATLANTA, 2016-09-14 15:00 CEST (GLOBE NEWSWIRE) -- CP Kelco, a leading global producer of specialty hydrocolloid solutions, announced today that its “diutan gum” has been approved by the United States Environmental Protection Agency (EPA) for use as an inert ingredient in agricultural chemical applications. As the leading manufacturer of diutan gum globally, CP Kelco can now offer this product for use in agricultural chemical applications for the US market.
“This approval from the US EPA enables CP Kelco to introduce an innovative solution to the AgChem segment and reinforce our commitment to serving this segment, now and in the future,” said Jérôme Béra, Senior Vice President of Global Marketing & Commercial at CP Kelco. “Diutan gum is one of the latest innovations in our specialty hydrocolloids portfolio to address opportunities and challenges in various industrial applications.”
According to the EPA’sfinal rule, diutan gum can be used as an inert ingredient stabilizer/suspension agent in pre- and post-harvest crop products. The inert clearance for diutan gum applies to potential uses such as:
- Crop protection applications, including herbicides, insecticides and fungicides;
- Pesticide products for animal production, such as topical insecticide sprays, gels, or pour-on liquids, as well as for use with companion animals, such as dogs and cats;
- Products for professional pest control, home lawn and garden, and turf management for golf courses and sports stadiums.
CP Kelco will market diutan gum products to the agrochemical industry under the following brand names which have been registered with EPA:
- KELCO-VIS™DG F
- KELCO-VIS™DG S
Diutan gum is a unique, anionic polymer produced by microbial fermentation. As a versatile rheology modifying agent, diutan gum is useful in a wide range of industrial applications, providing excellent stabilization, high pseudoplasticity and high viscosity at low-use concentrations.
CP Kelco also offers KELZAN™ AP and KELZAN™ S PLUS xanthan gums as ingredients for agricultural chemical applications; these offerings are part of the company’s portfolio of specialty xanthan gum products.
About CP Kelco
Headquartered in Atlanta, Georgia, USA, CP Kelco is a leading producer of specialty hydrocolloids with offices and facilities across the globe. Featuring an extensive range of hydrocolloid solutions and serving over 100 countries, CP Kelco leverages its capabilities to bring concepts and ideas to real-world products in a broad range of applications. The company’s specialty ingredients touch a wide variety of consumer and household products and industrial applications, tailored to meet the needs of regional consumers. Key product lines areGellan Gum,Pectin,Xanthan Gum,Carrageenan,Diutan Gum,Carboxymethyl Cellulose/Cellulose GumandMicroparticulated Whey Protein Concentrate, as well as other unique biopolymers. Visitwww.cpkelco.comfor more information.
Director of Global Communications
Office: +1 678 247 7149
Mobile: +1 770 743 0564
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
Concord Technologies24.9.2018 23:13 | pressemeddelelse
Concord Technologies Unveils NEXTSTEP—AI-driven, Cloud-based Platform that Simplifies Patient Data Capture and Document Workflows
IASLC24.9.2018 20:27 | pressemeddelelse
World Conference on Lung Cancer Monday Press Conference: Clinical Research Results and Gender Differences in Lung Cancer Survival
Mitratech24.9.2018 16:02 | pressemeddelelse
Mitratech Launches Latest TeamConnect ELM Innovations at Interact
Seclore24.9.2018 15:01 | pressemeddelelse
Seclore Offers the First Open Data-Centric Security Platform
XBiotech Inc.24.9.2018 14:32 | pressemeddelelse
XBiotech Announces Completion of U.S. Enrollment in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Hidradenitis Suppurativa
IASLC24.9.2018 01:02 | pressemeddelelse
Researchers, Survivors, Advocates and Physicians Convene to Discuss Innovations in Lung Cancer Research, Treatment and Advocacy at the Largest-Attended World Conference on Lung Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum